IV Thrombolysis vs Early Dual Antiplatelet Therapy in Patients With Mild Noncardioembolic Ischemic Stroke.
Marek SykoraStefan KrebsDominika MiksovaInes BadicThomas GattringerAuthor S Simon Fandler-HöflerMartha MarkoStefan GreiseneggerMichael KnoflachWilfried LangJulia Ferrarinull nullPublished in: Neurology (2023)
This study provides Class III evidence that IVT is not superior to dual antiplatelet therapy in patients with acute mild (NIHSS<=3) non-cardioembolic stroke. The study lacks the statistical precision to exclude clinically important superiority of either therapy.